We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
-22.69%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$116M
AUM Growth
+$3.75M
Cap. Flow
+$27.9M
Cap. Flow %
24.04%
Top 10 Hldgs %
40.13%
Holding
98
New
21
Increased
22
Reduced
11
Closed
4

Top Buys

1
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$5.4M
2
DERM
Dermira, Inc.
DERM
+$4.22M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$3.03M
4
NVAX icon
Novavax
NVAX
+$2.97M
5
ALDR
Alder Biopharmaceuticals
ALDR
+$2.83M

Top Sells

1
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$3.93M
2
CYTR
CytRx Corp
CYTR
+$1.54M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$725K
4
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
+$596K
5
LOXO
Loxo Oncology, Inc
LOXO
+$476K

Sector Composition

1 Healthcare 73.46%
2 Financials 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRC icon
1
AtriCure
ATRC
$1.75B
$8.22M 7.09%
488,446
+500
+0.1% +$8.8K
ABBV icon
2
AbbVie
ABBV
$436B
$6.66M 5.74%
116,581
– –
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
$5.94M 5.13%
396,554
+30,000
+8% +$503K
VTAE
4
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$5.22M 4.5%
787,373
+594,149
+307% +$5.4M
RIGL icon
5
Rigel Pharmaceuticals
RIGL
$763M
$3.9M 3.37%
187,649
+76,675
+69% +$1.89M
DERM
6
DELISTED
Dermira, Inc.
DERM
$3.55M 3.07%
+171,881
New +$4.22M
PODD icon
7
Insulet
PODD
$11.1B
$3.52M 3.03%
106,018
– –
ALDR
8
DELISTED
Alder Biopharmaceuticals
ALDR
$3.44M 2.96%
140,313
+122,313
+680% +$2.83M
MRNS
9
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.05M 2.63%
141,625
– –
NBIX icon
10
Neurocrine Biosciences
NBIX
$17.2B
$3.02M 2.6%
+76,300
New +$3.03M
NVAX icon
11
Novavax
NVAX
$1.38B
$2.86M 2.46%
+27,675
New +$2.97M
BEAT
12
DELISTED
BioTelemetry, Inc.
BEAT
$2.75M 2.37%
235,645
– –
LKFT
13
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
$2.74M 2.37%
65,568
+35,568
+119% +$1.65M
RGLS
14
DELISTED
Regulus Therapeutics
RGLS
$2.71M 2.34%
3,263
+2,513
+335% +$2M
AGTC
15
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.34M 2.02%
167,192
+10,000
+6% +$147K
AERI
16
DELISTED
Aerie Pharmaceuticals
AERI
$2.19M 1.89%
179,769
+31,400
+21% +$497K
MASI
17
DELISTED
Masimo
MASI
$1.93M 1.66%
46,010
– –
QURE icon
18
uniQure
QURE
$2.81B
$1.89M 1.63%
158,907
+123,907
+354% +$1.83M
ACHN
19
DELISTED
Achillion Pharmaceuticals
ACHN
$1.83M 1.58%
236,500
– –
TVRD
20
Tvardi Therapeutics
TVRD
$28.9M
$1.66M 1.43%
7,418
+2,714
+58% +$811K
IBB icon
21
iShares Biotechnology ETF
IBB
$9.23B
$1.56M 1.35%
+18,000
New +$1.61M
STXS icon
22
Stereotaxis
STXS
$162M
$1.51M 1.3%
1,372,862
– –
BSTC
23
DELISTED
BioSpecifics Technologies Corp.
BSTC
$1.38M 1.19%
+39,704
New +$1.46M
XENE icon
24
Xenon Pharmaceuticals
XENE
$6.55B
$1.35M 1.16%
193,195
+95,465
+98% +$686K
RDUS
25
DELISTED
Radius Health, Inc.
RDUS
$1.34M 1.16%
+42,600
New +$1.47M
1
2 3 4

Similar funds

FGWP
Founders Grove Wealth Partners Richmond, Virginia $440M AUM 16.56% 1-Year Est. Return
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $440M AUM 17.66% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $440M AUM